Thalys Medical Technology Group (SHSE:603716) Accounts Payable: ¥163.9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603716 Thalys Medical Technology Group Corp SHSE:603716
43 GF Score
Price ¥17.08
GF Value ¥4.22
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Thalys Medical Technology Group Accounts Payable?

Thalys Medical Technology Group SHSE:603716 +4.08% 43 Accounts Payable is ¥163.9 Mil as of Jun. 2026. GuruFocus rates SHSE:603716 with a GF Score™ of 43/100 and a GF Value™ of ¥4.22 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Thalys Medical Technology Group's Accounts Payable for the quarter that ended in Jun. 2026 was ¥163.9 Mil.

Thalys Medical Technology Group's quarterly Accounts Payable declined from Dec. 2025 (¥260.8 Mil) to Mar. 2026 (¥206.7 Mil) and declined from Mar. 2026 (¥206.7 Mil) to Jun. 2026 (¥163.9 Mil).

Thalys Medical Technology Group's annual Accounts Payable declined from Dec. 2023 (¥747.1 Mil) to Dec. 2024 (¥730.7 Mil) and declined from Dec. 2024 (¥730.7 Mil) to Dec. 2025 (¥260.8 Mil).

Thalys Medical Technology Group Accounts Payable Related Terms

Thalys Medical Technology Group Accounts Payable Historical Data

* Premium members only.

The historical data trend for Thalys Medical Technology Group's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thalys Medical Technology Group Accounts Payable Chart

Thalys Medical Technology Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 566.36 724.88 747.10 730.75 260.82

Thalys Medical Technology Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 312.20 300.04 260.82 206.66 163.88
SHSE:603716
43GF Score
Thalys Medical Technology Group Corp SHSE:603716
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thalys Medical Technology Group Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ¥163.9 Mil mean?
Thalys Medical Technology Group (SHSE:603716) has a Accounts Payable of ¥163.9 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Thalys Medical Technology Group and its competitors.
Is Thalys Medical Technology Group's Accounts Payable too high?
Thalys Medical Technology Group's current Accounts Payable is ¥163.9 Mil. Overall, Thalys Medical Technology Group has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Thalys Medical Technology Group's Accounts Payable compare to TMO and DHR?
Thalys Medical Technology Group's Accounts Payable of ¥163.9 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Thalys Medical Technology Group and its competitors. Thalys Medical Technology Group's current Accounts Payable is ¥163.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thalys Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Thalys Medical Technology Group (SHSE:603716) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.22, compared to a current price of ¥17.08 — trading 304.7% above its estimated fair value. The current Accounts Payable is ¥163.9 Mil. Thalys Medical Technology Group's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Thalys Medical Technology Group (SHSE:603716), the current Accounts Payable is ¥163.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thalys Medical Technology Group (SHSE:603716) Overvalued in 2026?

Based on GuruFocus' analysis, Thalys Medical Technology Group stock appears to be overvalued. The current stock price of ¥17.08 is trading 304.7% above its estimated GF Value™ of ¥4.22. GuruFocus considers Thalys Medical Technology Group to be Significantly Overvalued.

Key valuation signals for SHSE:603716:

  • Accounts Payable: ¥163.9 Mil
  • GF Value™: ¥4.22 vs. price of ¥17.08 (304.7% above fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603716 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thalys Medical Technology Group Business Description

Address 1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
43GF Score

Get the complete analysis for SHSE:603716

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.08
Price
¥4.22
GF Value